MiR-29b Downregulation Induces Phenotypic Modulation of Vascular Smooth Muscle Cells: Implication for Intracranial Aneurysm Formation and Progression to Rupture

Cellular Physiology and Biochemistry

Volumn 41, Issue 2, 2017, Pages 510-518

  Sun, Liqian ^a   Zhao, Manman ^b   Zhang, Jingbo ^a   Lv, Ming ^a   Li, Youxiang ^a   Yang, Xinjian ^a   Liu, Aihua ^a   Wu, Zhongxue ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NORTH CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

ATG14; Autophagy; Intracranial aneurysm; MiR 29b; Phenotypic modulation; Vascular smooth muscle cell

Indexed keywords

AUTOPHAGY RELATED PROTEIN; AUTOPHAGY RELATED PROTEIN 14; AUTOPHAGY RELATED PROTEIN 5; BECLIN 1; MESSENGER RNA; MICRORNA 29B; SEQUESTOSOME 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ANTAGOMIR; ATG14 PROTEIN, HUMAN; ATG5 PROTEIN, HUMAN; MICRORNA; VESICULAR TRANSPORT ADAPTOR PROTEIN;

3' UNTRANSLATED REGION; ADULT; AGED; ANEURYSM RUPTURE; ARTICLE; AUTOPHAGY; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOCYTOCHEMISTRY; INTRACRANIAL ANEURYSM; LENTIVIRINAE; MALE; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE CELL; VERY ELDERLY; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL MOTION; CYTOLOGY; DISEASE EXACERBATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; RNA INTERFERENCE; VASCULAR SMOOTH MUSCLE; YOUNG ADULT;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ADULT; AGED; AGED, 80 AND OVER; ANTAGOMIRS; AUTOPHAGY; AUTOPHAGY-RELATED PROTEIN 5; AUTOPHAGY-RELATED PROTEINS; BECLIN-1; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DISEASE PROGRESSION; FEMALE; HUMANS; INTRACRANIAL ANEURYSM; MALE; MICRORNAS; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; PHENOTYPE; RNA INTERFERENCE; RNA, SMALL INTERFERING; YOUNG ADULT;

EID: 85011649955     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000456887     Document Type: Article

References (19)

1. Rinkel GJE: Natural history, epidemiology and screening of unruptured intracranial aneurysms. J Neuroradiol 2008; 35: 99-103.
2. Kataoka H: Molecular mechanisms of the formation and progression of intracranial aneurysms. Neurol Med Chir (Tokyo) 2015; 55: 214-229.
3. Frösen J: Smooth muscle cells and the formation, degeneration, and rupture of saccular intracranial aneurysm wall - A review of current pathophysiological knowledge. Transl Stroke Res 2014; 5: 347-356.
4. Starke RM, Chalouhi N, Ding D, Raper DM, Mckisic MS, Owens GK, Hasan DM, Medel R, Dumont AS: Vascular smooth muscle cells in cerebral aneurysm pathogenesis. Translational Stroke Research 2014; 5: 338-346.
5. Chen X, Zhao Y, Wang F, Bei Y, Xiao J, Yang C: MicroRNAs in Liver Regeneration. Cell Physiol Biochem 2015; 37: 615-628.
6. Jin H, Li C, Ge H, Jiang Y, Li Y: Circulating microRNA: A novel potential biomarker for early diagnosis of Intracranial Aneurysm Rupture a case control study. J Transl Med 2013; 11: 1-9.
7. Albinsson S, Sessa WC: Can microRNAs control vascular smooth muscle phenotypic modulation and the response to injury Physiol Genomics 2011; 43: 529-533.
8. Cheng Y, Liu X, Jian Y, Ying L, Xu DZ, Qi L, Deitch EA, Huo Y, Delphin ES, Zhang C: MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009; 105: 158-166.
9. Chistiakov DA, Sobenin IA, Orekhov AN, Bobryshev YV: Human MIR-221/222 in Physiological and Atherosclerotic Vascular Remodeling. Biomed Res Int 2015; 2015: 354517.
10. Xiao Q, Chen Q, Feng Y: MIRNA-34a reduces neointima formation through inhibiting smooth muscle cell proliferation and migration. J Mol Cell Cardiol 2015; 101: A116-A116.
11. Ali MS, Starke RM, Jabbour PM, Tjoumakaris SI, Gonzalez LF, Rosenwasser RH, Owens GK, Koch WJ, Greig NH, Dumont AS: TNF - A induces phenotypic modulation in cerebral vascular smooth muscle cells: Implications for cerebral aneurysm pathology. J Cereb Blood Flow Metab 2013; 33: 1564-1573.
12. Cheng Y, Wang B, Zhou H, Dang S, Jin M, Shi Y, Hao L, Yang Z, Zhang Y: Autophagy is Required for the Maintenance of Liver Progenitor Cell Functionality. Cell Physiol Biochem 2015; 36: 1163-1174.
13. De Meyer GR, Grootaert MO, Michiels CF, Kurdi A, Schrijvers DM, Martinet W: Autophagy in Vascular Disease. Circ Res 2015; 116: 468-479.
14. Salabei JK, Hill BG: Autophagic regulation of smooth muscle cell biology. Redox Biol 2014; 4: 97-103.
15. Salabei JK, Cummins TD, Singh M, Jones SP, Bhatnagar A, Hill BG: PDGF-mediated autophagy regulates vascular smooth muscle cell phenotype and resistance to oxidative stress. Biochem J 2013; 451: 375-388.
16. Li BH, Liao SQ, Yin YW, Long CY, Guo L, Cao XJ, Liu Y, Zhou Y, Gao CY, Zhang LL: Telmisartan-induced PPAR activity attenuates lipid accumulation in VSMCs via induction of autophagy. Mol Biol Rep 2015; 42: 179-186.
17. Xie C, Huang H, Sun X, Guo Y, Hamblin M, Ritchie RP, Garciabarrio MT, Zhang J, Chen YE: MicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppel-like factor 4. Stem Cells Dev 2011; 20: 205-210.
18. Hergenreider E, Boon RA, Heydt S, Tréguer K, Böttger T, Horrevoets AJ, Zeiher AM, Braun T, Urbich C, Dimmeler S: Abstract 11676: Atheroprotective Communication Between Endothelial Cells and Smooth Muscle Cells via KLF2-Dependent Enrichment of MIRNAs in Microvesicles. Circulation 2011; 124: A11676.
19. Diao J, Liu R, Rong Y, Zhao M, Zhang J, Lai Y, Zhou Q, Wilz LM, Li J, Vivona S: ATG14 promotes membrane tethering and fusion of autophagosomes to endolysosomes. Nature 2015; 520: 563-566